Cubist Systematic Strategies, LLC Nektar Therapeutics Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.49 - $0.96 $11,644 - $22,814
-23,765 Reduced 99.83%
40 $0
Q4 2023

Feb 14, 2024
BUY
$0.42 - $0.57 $7,278 - $9,878
17,330 Added 267.64%
23,805 $13,000
Q3 2023

Nov 14, 2023
SELL
$0.51 - $1.05 $8,663 - $17,837
-16,988 Reduced 72.4%
6,475 $3,000
Q2 2023

Aug 14, 2023
SELL
$0.53 - $1.03 $20,121 - $39,103
-37,965 Reduced 61.8%
23,463 $13,000
Q1 2023

May 15, 2023
SELL
$0.64 - $3.15 $195,055 - $960,038
-304,774 Reduced 83.23%
61,428 $42,000
Q4 2022

Feb 14, 2023
BUY
$2.03 - $4.28 $327,416 - $690,316
161,289 Added 78.71%
366,202 $827,000
Q3 2022

Nov 14, 2022
SELL
$3.04 - $5.14 $174,331 - $294,758
-57,346 Reduced 21.87%
204,913 $656,000
Q2 2022

Aug 15, 2022
SELL
$3.17 - $6.17 $2 Million - $3.89 Million
-630,583 Reduced 70.63%
262,259 $997,000
Q1 2022

May 16, 2022
BUY
$4.16 - $13.72 $1.52 Million - $5.03 Million
366,493 Added 69.63%
892,842 $4.81 Million
Q4 2021

Feb 14, 2022
BUY
$10.83 - $18.41 $4.06 Million - $6.9 Million
374,552 Added 246.75%
526,349 $7.11 Million
Q3 2021

Nov 15, 2021
BUY
$13.07 - $18.84 $1.16 Million - $1.66 Million
88,372 Added 139.33%
151,797 $2.73 Million
Q2 2021

Aug 16, 2021
SELL
$16.52 - $20.4 $732,017 - $903,944
-44,311 Reduced 41.13%
63,425 $1.09 Million
Q1 2021

May 17, 2021
SELL
$16.56 - $25.46 $662,184 - $1.02 Million
-39,987 Reduced 27.07%
107,736 $2.16 Million
Q4 2020

Feb 16, 2021
BUY
$15.77 - $19.03 $992,469 - $1.2 Million
62,934 Added 74.22%
147,723 $2.51 Million
Q3 2020

Nov 16, 2020
BUY
$16.59 - $24.79 $37,476 - $56,000
2,259 Added 2.74%
84,789 $1.41 Million
Q2 2020

Aug 14, 2020
BUY
$16.86 - $23.44 $809,499 - $1.13 Million
48,013 Added 139.1%
82,530 $1.91 Million
Q1 2020

May 15, 2020
SELL
$14.47 - $27.96 $160,588 - $310,300
-11,098 Reduced 24.33%
34,517 $616,000
Q4 2019

Feb 14, 2020
BUY
$15.87 - $23.12 $232,733 - $339,054
14,665 Added 47.38%
45,615 $985,000
Q3 2019

Nov 14, 2019
SELL
$16.91 - $36.27 $1.17 Million - $2.51 Million
-69,183 Reduced 69.09%
30,950 $564,000
Q2 2019

Aug 14, 2019
SELL
$31.0 - $36.3 $449,159 - $525,950
-14,489 Reduced 12.64%
100,133 $3.56 Million
Q1 2019

May 15, 2019
BUY
$31.58 - $46.35 $3.62 Million - $5.31 Million
114,622 New
114,622 $3.85 Million
Q4 2018

Feb 14, 2019
SELL
$30.43 - $56.65 $100,053 - $186,265
-3,288 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$46.46 - $68.49 $174,550 - $257,316
-3,757 Reduced 53.33%
3,288 $200,000
Q2 2018

Aug 14, 2018
SELL
$46.25 - $104.45 $1.66 Million - $3.76 Million
-35,955 Reduced 83.62%
7,045 $344,000
Q1 2018

May 15, 2018
BUY
$57.4 - $108.44 $2.47 Million - $4.66 Million
43,000 New
43,000 $4.57 Million

Others Institutions Holding NKTR

# of Institutions
140
Shares Held
135M
Call Options Held
32.8K
Put Options Held
55.5K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email